4.6 Review

Luteolin, a Potent Anticancer Compound: From Chemistry to Cellular Interactions and Synergetic Perspectives

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Food Science & Technology

Modulation of inflammation by phytochemicals to enhance efficacy and reduce toxicity of cancer chemotherapy

Taha Koray Sahin et al.

Summary: Chemotherapy for cancer treatment is accompanied by various side effects and the eventual development of resistance. Complementary therapies, such as botanicals and nutritional supplements, with minimal side effects are needed to prevent resistance and reduce adverse effects. Inflammation plays a key role in chemoresistance and chemotherapy-induced adverse effects. Phytochemicals have established anti-inflammatory effects and can be used as complementary therapies to enhance the efficacy and reduce the toxicity of chemotherapy.

CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2023)

Article Biochemistry & Molecular Biology

The effect of hesperidin and luteolin isolated fromEriocephalus africanuson apoptosis, cell cycle and miRNA expression in MCF-7

Judie Magura et al.

Summary: This study investigates the molecular mechanisms underlying the anticancer activity of hesperidin and luteolin in breast cancer cell lines. The results showed that hesperidin and luteolin induced apoptosis in breast cancer cells through various mechanisms, leading to a reduction in cell viability. Additionally, they also modulated the expression of specific apoptotic regulatory genes and apoptotic microRNAs.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)

Article Biochemical Research Methods

A rapid HPLC-MS/MS method for the simultaneous determination of luteolin, resveratrol and their metabolites in rat plasma and its application to pharmacokinetic interaction studies

Wenying Wu et al.

Summary: This study developed an HPLC-MS/MS method for simultaneous determination of LUT, LUT-3'-G, RES, and RES-3-G in rat plasma to investigate the impact of RES on the bioavailability and metabolism of LUT. The results indicated that RES significantly enhanced the bioavailability of LUT, providing a reference for the combination therapy of LUT and RES in liver diseases.

JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2022)

Review Chemistry, Medicinal

Phytochemicals mediated modulation of microRNAs and long non-coding RNAs in cancer prevention and therapy

Luis M. Ruiz-Manriquez et al.

Summary: Noncoding RNAs, such as miRNAs and lncRNAs, play crucial roles in cancer initiation and progression, and their expression can be modulated by phytochemicals to inhibit cancer development. Although some clinical trials are ongoing, further research is needed to fully understand the therapeutic effects of phytochemicals in cancer treatment.

PHYTOTHERAPY RESEARCH (2022)

Article Agronomy

Combination Effects of Polyphenols Present in Sugarcane on Proliferation in MCF-7 Human Breast Cancer Cells

Yujiao Yang et al.

Summary: Sugarcane is rich in polyphenols, including quercetin, apigenin, luteolin, tricin, and p-coumaric acid, which have shown inhibitory effects against MCF-7 breast cancer cells. The combination of luteolin and p-coumaric acid exhibited synergistic effects at all tested concentrations, while luteolin combined with apigenin showed synergistic effects at high inhibition rates. synergistic relation among polyphenols present in sugarcane in inhibition of cancer cell growth.

SUGAR TECH (2022)

Article Endocrinology & Metabolism

Luteolin Potentially Treating Prostate Cancer and COVID-19 Analyzed by the Bioinformatics Approach: Clinical Findings and Drug Targets

Yu Ye et al.

Summary: This study investigates the potential drug target and curative mechanism of luteolin as a treatment for prostate cancer and COVID-19. Through differential gene expression analysis and network pharmacology, it is found that luteolin exhibits anti-inflammatory effects, improves metabolism, and enhances immunity. Luteolin may serve as a promising treatment for prostate cancer and COVID-19 based on bioinformatics findings.

FRONTIERS IN ENDOCRINOLOGY (2022)

Article Oncology

Luteolin Induces Apoptosis and Autophagy in HCT116 Colon Cancer Cells via p53-Dependent Pathway

Ho Soo Yoo et al.

Summary: The study suggests that luteolin inhibits the growth of colon cancer cells through enhancing p53 activity to induce apoptosis and cell cycle arrest in a p53-dependent manner, regardless of the induction of autophagy.

NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2022)

Article Pharmacology & Pharmacy

Luteolin binds Src, promotes STAT3 protein ubiquitination and exerts anti-melanoma effects in cell and mouse models

Ting Li et al.

Summary: This study demonstrates that luteolin has both in vitro and in vivo anti-melanoma effects. It reduces melanoma cell viability, induces apoptosis, and suppresses migration and invasion. Luteolin inhibits STAT3 signaling and promotes STAT3 protein degradation, thereby regulating the expression of genes involved in cell survival and invasion. These findings provide a pharmacological basis for developing luteolin as a chemopreventive agent against melanoma.

BIOCHEMICAL PHARMACOLOGY (2022)

Article Biochemistry & Molecular Biology

Luteolin Causes 5′CpG Demethylation of the Promoters of TSGs and Modulates the Aberrant Histone Modifications, Restoring the Expression of TSGs in Human Cancer Cells

Sreepoorna Pramodh et al.

Summary: This study analyzed the epigenetic modulatory behavior of luteolin on HeLa cells and found that luteolin can inhibit migration and colony formation in HeLa cells. It can also reactivate silenced tumor suppressor genes by modulating DNA methylation, enzyme activity, and global DNA methylation. Therefore, luteolin-targeted epigenetic alterations provide a potential approach for cancer prevention and intervention.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Cell Biology

HO-1 Contributes to Luteolin-Triggered Ferroptosis in Clear Cell Renal Cell Carcinoma via Increasing the Labile Iron Pool and Promoting Lipid Peroxidation

Shangting Han et al.

Summary: Luteolin (Lut), a natural compound, has been shown to inhibit the survival of clear cell renal cell carcinoma (ccRCC) by activating iron-dependent cell death mechanism known as ferroptosis.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2022)

Article Anatomy & Morphology

Luteolin inhibits viability, migration, angiogenesis and invasion of non-small cell lung cancer vascular endothelial cells via miR-133a-3p/purine rich element binding protein B-mediated MAPK and PI3K/Akt signaling pathways

Jie Pan et al.

Summary: Luteolin inhibits the migration and invasion of NSCLC-VECs through the miR-133a-3p/PURB-mediated MAPK and PI3K/Akt pathways.

TISSUE & CELL (2022)

Article Nutrition & Dietetics

Anti-Inflammatory and Active Biological Properties of the Plant-Derived Bioactive Compounds Luteolin and Luteolin 7-Glucoside

Sabrina Caporali et al.

Summary: Flavonoids are interesting molecules synthesized by plants, with important nutritional and anti-inflammatory properties in the human body. The biochemical properties of flavonoid molecules provide new perspectives for long-term health in healthy individuals, as well as their use as adjunctive treatment for specific diseases.

NUTRIENTS (2022)

Article Biotechnology & Applied Microbiology

Luteolin impacts deoxyribonucleic acid repair by modulating the mitogen-activated protein kinase pathway in colorectal cancer

Yelin Song et al.

Summary: The study found that luteolin exerts inhibitory effects on colorectal cancer cells through various pathways, including inhibiting cell growth, inducing apoptosis, blocking the cell cycle, and inducing DNA damage. In cell experiments, the combination of luteolin and cisplatin significantly increased the apoptosis rate of cells. Bioinformatic analysis revealed the involvement of the MAPK pathway in the pharmacological effects of luteolin.

BIOENGINEERED (2022)

Article Pharmacology & Pharmacy

Novel Luteolin-Loaded Chitosan Decorated Nanoparticles for Brain-Targeting Delivery in a Sporadic Alzheimer's Disease Mouse Model: Focus on Antioxidant, Anti-Inflammatory, and Amyloidogenic Pathways

Haidy Abbas et al.

Summary: In this study, a non-invasive intranasal delivery system using novel chitosan decorated nanoparticles was developed and evaluated for the treatment of cognitive dysfunction in Alzheimer's disease. The results showed that the chitosan decorated nanoparticles improved cognitive function in an animal model of Alzheimer's disease, indicating their potential as a safe and effective therapeutic approach.

PHARMACEUTICS (2022)

Article Biochemistry & Molecular Biology

Luteolin Synergistically Enhances Antitumor Activity of Oxaliplatin in Colorectal Carcinoma via AMPK Inhibition

Chan Ho Jang et al.

Summary: This study demonstrates the synergistic anticancer effect of luteolin and oxaliplatin in suppressing colorectal cancer growth in vivo. It suggests the potential of luteolin as an adjunct therapy for colorectal cancer treatment.

ANTIOXIDANTS (2022)

Article Oncology

Luteolin attenuates the chemoresistance of osteosarcoma through inhibiting the PTN/0-catenin/MDR1 signaling axis by upregulating miR-384

Tao Qin et al.

Summary: Luteolin reverses multidrug resistance in osteosarcoma cells by regulating PTN expression via miR-384. It enhances chemosensitivity to doxorubicin and cisplatin and inhibits the MDR1 signaling axis. Furthermore, luteolin effectively packages miR-384 into secreted exosomes, which improves doxorubicin response in doxorubicin-resistant cells.

JOURNAL OF BONE ONCOLOGY (2022)

Article Acoustics

Effects of ultrasonic pretreatment of soybean protein isolate on the binding efficiency, structural changes, and bioavailability of a protein-luteolin nanodelivery system

Fuwei Sun et al.

Summary: This study investigated the use of ultrasound pretreatment to improve the encapsulation efficacy, solubility, and stability of a soybean protein isolate-luteolin nano-delivery system. The results demonstrated that ultrasound pretreatment enhanced the performance of the system, including increased loading amount and solubility, decreased particle size, and improved thermal stability. It also showed that ultrasound pretreatment increased the release rate and antioxidant activity of the nano-delivery system. This research provides preliminary evidence for the development of ultrasound pretreatment in the construction of protein-based nano-delivery systems.

ULTRASONICS SONOCHEMISTRY (2022)

Article Oncology

Combined Curcumin and Luteolin Synergistically Inhibit Colon Cancer Associated with Notch1 and TGF-β Signaling Pathways in Cultured Cells and Xenograft Mice

Rukayat Aromokeye et al.

Summary: This study demonstrates that the combination of luteolin and curcumin at low dosages synergistically inhibits colon cancer growth by suppressing cell proliferation, migration, and promoting necrosis through the Notch1 and TGF-beta pathways. These findings suggest that consuming foods with high levels of luteolin and curcumin may be a practical approach for the prevention and treatment of colon cancer.

CANCERS (2022)

Article Pharmacology & Pharmacy

Luteolin induces pyroptosis in HT-29 cells by activating the Caspase1/Gasdermin D signalling pathway

Yiliu Chen et al.

Summary: This study discovered that luteolin inhibits the proliferation of colon cancer cells by modulating the pyroptosis pathway, providing a new direction for the development of natural products that inhibit tumor growth.

FRONTIERS IN PHARMACOLOGY (2022)

Article Medicine, General & Internal

Luteolin Reduces Aqueous Extract PM2.5-induced Metastatic Activity in H460 Lung Cancer Cells

Hui-Wen Lin et al.

Summary: Luteolin was found to reduce cell migration and the expression of pro-metastatic factors in PM2.5-exposed lung cancer cells. It also inhibited the PM2.5-induced signaling pathway and reduced the production of certain proteins. These results suggest that luteolin exhibits antitumor progression by inhibiting the EGFR-PI3K-AKT pathway.

INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2022)

Article Chemistry, Multidisciplinary

Formulation and Evaluation of Luteolin-Loaded Nanovesicles: In Vitro Physicochemical Characterization and Viability Assessment

Syed Sarim Imam et al.

Summary: Luteolin-loaded nanovesicles were successfully prepared using the solvent evaporation method, showing nanometric size, optimum polydispersibility index, and negative zeta potential. These nanovesicles exhibited enhanced drug release and permeation properties, with significant variations in encapsulation efficiency depending on the composition. The antioxidant activity of LT-NVs was superior to pure luteolin, and cytotoxicity studies showed a lower IC50 value, suggesting their potential as a natural alternative for lung cancer treatment.

ACS OMEGA (2022)

Article Medical Laboratory Technology

Luteolin enhances the antitumor efficacy of oncolytic vaccinia virus that harbors IL-24 gene in liver cancer cells

Chunming Wang et al.

Summary: The combination of VV-IL-24 and luteolin showed a stronger inhibition of liver cancer cell viability, induced more apoptosis in liver cancer cells, and significantly inhibited tumor growth in the MHCC97-H xenograft model compared to single treatments, indicating a potential synergistic effect in the treatment of liver cancer.

JOURNAL OF CLINICAL LABORATORY ANALYSIS (2021)

Article Plant Sciences

Luteolin suppresses androgen receptor-positive triple-negative breast cancer cell proliferation and metastasis by epigenetic regulation of MMP9 expression via the AKT/mTOR signaling pathway

Han-Tsang Wu et al.

Summary: The study showed that luteolin effectively inhibited the proliferation and metastasis of androgen receptor-positive TNBC, reversing the epithelial-mesenchymal transition and downregulating MMP9 expression. The combination of luteolin and AKT/mTOR inhibitors synergistically suppressed the proliferation and metastasis of androgen receptor-positive TNBC cells.

PHYTOMEDICINE (2021)

Review Biochemistry & Molecular Biology

Luteolin, inflammation and cancer: Special emphasis on gut microbiota

Laura Franza et al.

Summary: Luteolin, a flavonoid compound, has anti-inflammatory effects and may be beneficial for patients with cancer, neuropsychiatric disorders, and inflammatory bowel conditions. With a long history of use in traditional Chinese medicine, luteolin's anti-inflammatory properties, especially in cancer, have been studied extensively.

BIOFACTORS (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Oncology

DPYD, down-regulated by the potentially chemopreventive agent luteolin, interacts with STAT3 in pancreatic cancer

Hiroyuki Kato et al.

Summary: The study found that the flavonoid Luteolin (Lut) has chemopreventive effects on pancreatic cancer in a hamster model, potentially through inhibiting the STAT3-DPYD pathway. Additionally, high expression of DPYD in human PDAC was associated with poor prognosis.

CARCINOGENESIS (2021)

Article Pharmacology & Pharmacy

Luteolin attenuates cancer cell stemness in PTX-resistant oesophageal cancer cells through mediating SOX2 protein stability

Jinzhu Zhao et al.

Summary: Luteolin attenuates the stem-like properties and migration ability of paclitaxel-resistant cancer cells through multiple mechanisms, demonstrating potential anti-tumor effects.

PHARMACOLOGICAL RESEARCH (2021)

Review Chemistry, Medicinal

Anticancer activity of the plant flavonoid luteolin against preclinical models of various cancers and insights on different signalling mechanisms modulated

Shabir Ahmad Ganai et al.

Summary: Various signaling mechanisms play a significant role in the development of multiple cancers, and flavonoids from plant sources are emerging as promising broad-spectrum anticancer agents. Luteolin, a flavonoid compound, exhibits anticancer activity against various cancers and has strong potential when used in combination with other therapeutics. Further research on luteolin may lead to novel insights for valuable studies on this promising compound.

PHYTOTHERAPY RESEARCH (2021)

Article Biochemistry & Molecular Biology

Luteolin-Fabricated ZnO Nanostructures Showed PLK-1 Mediated Anti-Breast Cancer Activity

Shiva Prasad Kollur et al.

Summary: A facile method for synthesizing zinc oxide nanoparticles using luteolin isolated from Eclipta alba plant (L-ZnONPs) at room temperature was described. The as-grown L-ZnONPs showed a Wurtzite structure, with anticancer activity against the breast cancer cell line MCF-7 mediated by polo-like kinase 1 (PLK1) proteins.

BIOMOLECULES (2021)

Article Engineering, Biomedical

Targeted PD-L1 PLGA/liposomes-mediated luteolin therapy for effective liver cancer cell treatment

Xinqiao Cao et al.

Summary: Stealth PLGA/Liposome nanoparticles modified with tumor-targeting PD-L1 antibody were prepared for systemic delivery of luteolin for liver cancer treatment. The nanoparticles showed enhanced drug uptake and inhibition of liver cancer cell proliferation, indicating their potential as an effective drug delivery system targeting PD-L1.

JOURNAL OF BIOMATERIALS APPLICATIONS (2021)

Article Cell Biology

Targeting LIMK1 with luteolin inhibits the growth of lung cancer in vitro and in vivo

Man Zhang et al.

Summary: The study revealed that luteolin inhibits lung cancer growth by targeting LIMK1 kinase activity, affecting signaling pathways, cell cycle, and apoptosis. This provides valuable insights for the translation of luteolin into clinical trials for lung cancer.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)

Review Oncology

Luteolin and cancer metastasis suppression: focus on the role of epithelial to mesenchymal transition

Yaseen Hussain et al.

Summary: Epithelial to mesenchymal transition (EMT) plays a key role in cancer metastasis, and luteolin, a natural flavonoid, inhibits cancer cell growth through various mechanisms, making it a potential drug for regulating cancer cell activity.

MEDICAL ONCOLOGY (2021)

Article Oncology

Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer

Ze-Bo Jiang et al.

Summary: The study showed that luteolin and apigenin can effectively inhibit the proliferation of KRAS-mutant lung cancer cells, reduce the expression of IFN-gamma-induced PD-L1, and induce apoptosis by suppressing STAT3 phosphorylation. Combined treatment with PD-1 blockade and apigenin/luteolin had a synergistic effect, offering a potential therapeutic strategy for NSCLC with KRAS mutations.

CANCER LETTERS (2021)

Article Ophthalmology

Luteolin inhibits the proliferation, adhesion, migration and invasion of choroidal melanoma cells in vitro

Meng-Lin Shi et al.

Summary: Luteolin has inhibitory effects on choroidal melanoma cells and acts through the PI3K/Akt signaling pathway. This study provides a new theoretical basis for the potential use of luteolin as a therapeutic medication for choroidal melanoma.

EXPERIMENTAL EYE RESEARCH (2021)

Article Multidisciplinary Sciences

Syntheses of mono-acylated luteolin derivatives, evaluation of their antiproliferative and radical scavenging activities and implications on their oral bioavailability

Stephen Lo et al.

Summary: Ten mono-acyl derivatives of luteolin were synthesized and some showed improved antiproliferative activity with comparable radical scavenging activity. The study suggests that increasing lipophilicity in flavonoids can enhance bioavailability and potentially improve therapeutic potential.

SCIENTIFIC REPORTS (2021)

Article Medicine, General & Internal

Role of Luteolin-Induced Apoptosis and Autophagy in Human Glioblastoma Cell Lines

Hye-Sung Lee et al.

Summary: Luteolin can induce apoptosis and autophagy in malignant glioblastoma cells, suggesting its therapeutic potential for GBM.

MEDICINA-LITHUANIA (2021)

Review Biochemistry & Molecular Biology

Impacting the Remedial Potential of Nano Delivery-Based Flavonoids for Breast Cancer Treatment

Rakesh K. Sindhu et al.

Summary: Flavonoids, a type of polyphenol, show potential in the treatment of breast cancer by regulating tumor-related functions. Plant polyphenols have antioxidant and anticarcinogenic properties that contribute to breast cancer prevention and treatment. Nanotechnology-based approaches may enhance the activity of phyto-bioactive compounds and improve early detection of cancer.

MOLECULES (2021)

Review Biochemistry & Molecular Biology

Current evidence to support the therapeutic potential of flavonoids in oxidative stress-related dermatoses

Dehai Xian et al.

Summary: Oxidative stress is a redox imbalance caused by an excess of oxidants over antioxidants, leading to various skin diseases. Flavonoids, as plant secondary metabolites, have potent antioxidant capacity and can effectively suppress oxidative stress, playing a role in preventing and managing oxidative stress-related skin disorders.

REDOX REPORT (2021)

Review Surgery

Breast Cancer Apoptosis and the Therapeutic Role of Luteolin

Zacharias Fasoulakis et al.

Summary: Breast cancer is one of the most common gynecological cancers, with each subtype requiring distinct treatment strategies. The optimal therapy depends on tumor subtype, stage, and patient preferences. Surgical interventions have become less complex, while new hormonal and chemotherapeutic drugs show promising results.

CHIRURGIA (2021)

Article Biotechnology & Applied Microbiology

Luteolin Suppresses the Proliferation of Gastric Cancer Cells and Acts in Synergy with Oxaliplatin

Li-Qun Ren et al.

BIOMED RESEARCH INTERNATIONAL (2020)

Article Pharmacology & Pharmacy

Luteolin impairs hypoxia adaptation and progression in human breast and colon cancer cells

Elena Monti et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2020)

Article Urology & Nephrology

Cell-Based Phenotypic Drug Screening Identifies Luteolin as Candidate Therapeutic for Nephropathic Cystinosis

Ester De Leo et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)

Review Oncology

Autophagy regulation using luteolin: new insight into its anti-tumor activity

Milad Ashrafizadeh et al.

CANCER CELL INTERNATIONAL (2020)

Review Medicine, Research & Experimental

Luteolin, a flavonoid, as an anticancer agent: A review

Muhammad Imran et al.

BIOMEDICINE & PHARMACOTHERAPY (2019)

Review Biochemistry & Molecular Biology

Novel extraction techniques and pharmaceutical activities of luteolin and its derivatives

Muhammad Faisal Manzoor et al.

JOURNAL OF FOOD BIOCHEMISTRY (2019)

Article Biotechnology & Applied Microbiology

Luteolin exhibits anti-breast cancer property through up-regulating miR-203

Guanglei Gao et al.

ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2019)

Article Biochemistry & Molecular Biology

Regulation of apoptosis and autophagy by luteolin in human hepatocellular cancer Hep3B cells

Yujin Lee et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)

Article Food Science & Technology

Influence of luteolin on the apoptosis of esophageal cancer Eca109 cells and its mechanism of action

Shaokang Wang et al.

FOOD SCIENCE AND HUMAN WELLNESS (2019)

Review Biotechnology & Applied Microbiology

Can luteolin be a therapeutic molecule for both colon cancer and diabetes?

Rashmi K. Ambasta et al.

BRIEFINGS IN FUNCTIONAL GENOMICS (2019)

Article Biochemistry & Molecular Biology

Luteolin Inhibits Tumorigenesis and Induces Apoptosis of Non-Small Cell Lung Cancer Cells via Regulation of MicroRNA-34a-5p

Ze-Qun Jiang et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Article Biochemistry & Molecular Biology

Synergism between luteolin and sulforaphane in anti-inflammation

Kanyasiri Rakariyatham et al.

FOOD & FUNCTION (2018)

Article Agriculture, Multidisciplinary

Absorption and Metabolism of Luteolin in Rats and Humans in Relation to in Vitro Anti-inflammatory Effects

Natsumi Hayasaka et al.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2018)

Review Oncology

Mechanism of metastasis suppression by luteolin in breast cancer

Matthew T. Cook

BREAST CANCER-TARGETS AND THERAPY (2018)

Article Medicine, Research & Experimental

Luteolin protects mice from severe acute pancreatitis by exerting HO-1-mediated anti-inflammatory and antioxidant effects

Jie Xiong et al.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2017)

Article Oncology

Luteolin inhibits angiogenesis by blocking Gas6/Axl signaling pathway

Xiaobo Li et al.

INTERNATIONAL JOURNAL OF ONCOLOGY (2017)

Article Oncology

Luteolin induces apoptotic cell death via antioxidant activity in human colon cancer cells

Kyoung Ah Kang et al.

INTERNATIONAL JOURNAL OF ONCOLOGY (2017)

Review Biotechnology & Applied Microbiology

MicroRNA therapeutics: towards a new era for the management of cancer and other diseases

Rajesha Rupaimoole et al.

NATURE REVIEWS DRUG DISCOVERY (2017)

Article Cell Biology

Luteolin Promotes Cell Apoptosis by Inducing Autophagy in Hepatocellular Carcinoma

Zhijia Cao et al.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)

Review Oncology

Molecular targets of luteolin in cancer

Muobarak J. Tuorkey

EUROPEAN JOURNAL OF CANCER PREVENTION (2016)

Article Agriculture, Multidisciplinary

Metabolic Fate of Luteolin in Rats: Its Relationship to Anti-inflammatory Effect

Ayako Kure et al.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2016)

Article Veterinary Sciences

Therapeutic anti-inflammatory effects of luteolin on endotoxin-induced uveitis in Lewis rats

Kazutaka Kanai et al.

JOURNAL OF VETERINARY MEDICAL SCIENCE (2016)

Review Genetics & Heredity

A network-biology perspective of microRNA function and dysfunction in cancer

Cameron P. Bracken et al.

NATURE REVIEWS GENETICS (2016)

Article Plant Sciences

MicroRNA858 Is a Potential Regulator of Phenylpropanoid Pathway and Plant Development

Deepika Sharma et al.

PLANT PHYSIOLOGY (2016)

Article Biotechnology & Applied Microbiology

Luteolin inhibited proliferation and induced apoptosis of prostate cancer cells through miR-301

Kun Han et al.

ONCOTARGETS AND THERAPY (2016)

Article Chemistry, Medicinal

Exploring quercetin and luteolin derivatives as antiangiogenic agents

Divyashree Ravishankar et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)

Article Agriculture, Multidisciplinary

Absorption and Metabolism of Luteolin and its Glycosides from the Extract of Chrysanthemum morifolium Flowers in Rats and Caco-2 Cells

Michiko Torii Yasuda et al.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2015)

Article Medicine, Research & Experimental

Luteolin exerts a marked antitumor effect in cMet-overexpressing patient-derived tumor xenograft models of gastric cancer

Jun Lu et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2015)

Article Medicine, Research & Experimental

Luteolin inhibits ROS-activated MAPK pathway in myocardial ischemia/reperfusion injury

Dongsheng Yu et al.

LIFE SCIENCES (2015)

Article Oncology

Luteolin Induces Apoptosis by Up-regulating miR-34a in Human Gastric Cancer Cells

Hao Wu et al.

TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2015)

Article Pharmacology & Pharmacy

MEDICINAL PLANTS: THEIR USE IN ANTICANCER TREATMENT

M. Greenwell et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH (2015)

Review Oncology

MicroRNA biogenesis pathways in cancer

Shuibin Lin et al.

NATURE REVIEWS CANCER (2015)

Review Immunology

Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity

Jason W. Griffith et al.

ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)

Review Oncology

Luteolin, a Bioflavonoid Inhibits Colorectal Cancer through Modulation of Multiple Signaling Pathways: A Review

Ashok Kumar Pandurangan et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)

Article Biochemistry & Molecular Biology

Luteolin inhibits the Nrf2 signaling pathway and tumor growth in vivo

Song Chian et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)

Review Biochemistry & Molecular Biology

Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease

Mark D. Turner et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2014)

Article Toxicology

Luteolin Induces Cell Cycle Arrest and Apoptosis Through Extrinsic and Intrinsic Signaling Pathways in MCF-7 Breast Cancer Cells

Su-Ho Park et al.

JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY (2014)

Article Chemistry, Multidisciplinary

Total synthesis of luteolin

Ji Zhang et al.

JOURNAL OF CHEMICAL RESEARCH (2014)

Article Chemistry, Medicinal

Raf and PI3K are the Molecular Targets for the Anti-metastatic Effect of Luteolin

Ho Young Kim et al.

PHYTOTHERAPY RESEARCH (2013)

Article Biochemistry & Molecular Biology

Molecules and their functions in autophagy

Jong-Ok Pyo et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2012)

Article Gastroenterology & Hepatology

Oridonin induces apoptosis in gastric cancer through Apaf-1, cytochrome c and caspase-3 signaling pathway

Ke-Wang Sun et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2012)

Review Biochemistry & Molecular Biology

The Beclin 1 network regulates autophagy and apoptosis

R. Kang et al.

CELL DEATH AND DIFFERENTIATION (2011)

Article Biochemistry & Molecular Biology

Luteolin inhibits cytokine expression in endotoxin/cytokine-stimulated microglia

Tsung-Kuei Kao et al.

JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2011)

Article Oncology

Luteolin inhibits invasion of prostate cancer PC3 cells through E-cadherin

Qiong Zhou et al.

MOLECULAR CANCER THERAPEUTICS (2009)

Article Cell Biology

The NF-κB Family of Transcription Factors and Its Regulation

Andrea Oeckinghaus et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2009)

Article Cell Biology

The Nuclear Factor NF-κB Pathway in Inflammation

Toby Lawrence

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2009)

Review Oncology

Luteolin, a Flavonoid with Potential for Cancer Prevention and Therapy

Yong Lin et al.

CURRENT CANCER DRUG TARGETS (2008)

Review Biochemistry & Molecular Biology

Anti-carcinogenic Effects of the Flavonoid Luteolin

Guenter Seelinger et al.

MOLECULES (2008)

Review Plant Sciences

Anti-Oxidant, Anti-inflammatory and Anti-Allergic Activities of Luteolin

Guenter Seelinger et al.

PLANTA MEDICA (2008)

Article Biochemistry & Molecular Biology

Induction of cancer cell apoptosis by flavonoids is associated with their ability to inhibit fatty acid synthase activity

K Brusselmans et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2005)